References

Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms

10.1126/sciadv.1501632 · 2016 · External reference

Biofilm formation - what we can learn from recent developments

10.1111/joim.12782 · 2018 · External reference

Mouse models to study wound closure and topical treatment of infected wounds in healing-impaired and normal healing hosts

10.1046/j.1524-475x.1997.50213.x · 1997 · External reference

Gram staining

10.1002/9780471729259 · 2005 · External reference

Microbial biofilms

10.1146/annurev.mi.49.100195.003431 · 1995 · External reference

The use of commercially available alpha-amylase compounds to inhibit and remove Staphylococcus aureus biofilms

10.2174/1874285801105010021 · 2011 · External reference

An in vivo polymicrobial biofilm wound infection model to study interspecies interactions

10.1371/journal.pone.0027317 · 2011 · External reference

Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model

10.1128/iai.02198-14 · 2014 · External reference

Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds

10.1128/aac.01998-16 · 2017 · External reference

The consequences of biofilm dispersal on the host

10.1038/s41598-018-29121-2 · 2018 · External reference

The biofilm matrix

10.1038/nrmicro2415 · 2010 · External reference

Biofilms: an emergent form of bacterial life

10.1038/nrmicro.2016.94 · 2016 · External reference

AhrC and Eep are biofilm infection-associated virulence factors in Enterococcus faecalis

10.1128/iai.01210-12 · 2013 · External reference

Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture

10.1128/aem.00637-11 · 2011 · External reference

Chromosomal genetics of Pseudomonas

10.1128/mr.43.1.73-102.1979 · 1979 · External reference

Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS

10.1177/154405910708600707 · 2007 · External reference

Antibiofilm activity of alpha-amylase from Bacillus subtilis S8-18 against biofilm forming human bacterial pathogens

10.1007/s12010-011-9526-2 · 2012 · External reference

Targeting microbial biofilms: current and prospective therapeutic strategies

10.1038/nrmicro.2017.99 · 2017 · External reference

Persister cells: molecular mechanisms related to antibiotic tolerance

10.1007/978-3-642-28951-4_8 · 2012 · External reference

Assembly and development of the Pseudomonas aeruginosa biofilm matrix

10.1371/journal.ppat.1000354 · 2009 · External reference

Pseudomonas aeruginosa PAO1 exopolysaccharides are important for mixed species biofilm community development and stress tolerance

10.3389/fmicb.2015.00851 · 2015 · External reference

Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents

10.1128/aac.01418-09 · 2010 · External reference

Quorum sensing and the social evolution of bacterial virulence

10.1016/j.cub.2009.01.050 · 2009 · External reference

In vitro multispecies Lubbock chronic wound biofilm model

10.1111/j.1524-475x.2008.00434.x · 2008 · External reference

An enhanced antigen-retrieval protocol for immunohistochemical staining of formalin-fixed, paraffin-embedded tissues

10.1007/978-1-61779-024-9_6 · 2011 · External reference

Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms

10.1128/iai.00651-13 · 2014 · External reference

Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma

2016 · External reference

Quantitative and qualitative assessment methods for biofilm growth: a mini-review

2017 · External reference

Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window

10.12968/jowc.2010.19.8.77709 · 2010 · External reference

Distinct roles of extracellular polymeric substances in Pseudomonas aeruginosa biofilm development

10.1111/j.1462-2920.2011.02503.x · 2011 · External reference